(1 - 8 from 9
)
Dutch funds say J&J's Crucell move a starting point - EcoDiario.es
www.eleconomista.es
"It is not a done deal; we still have to make up our minds about whether to tender our shares," said Jack Jonk, head of equity at Delta Lloyd Asset Management.
Delta Lloyd vindt bod op Mediq te laag | Binnenland | Telegraaf.nl
www.telegraaf.nl
Delta Lloyd Asset Management, dat circa 14 procent bezit van medisch toeleverancier Mediq, vindt het bod van Advent op het bedrijf te laag. Dat liet het hoofd...
Johnson & Johnson Reaches Deal for Crucell - The New York Times
dealbook.nytimes.com
“We would not tender our shares at this price,” Jack Jonk, chief of equity at Delta Lloyd Asset Management, which holds about 4 percent in Crucell,
sorted by relevance / date